Most radiologists report few meaningful clinical benefits from current breast imaging AI tools, despite rising adoption.
Key Details
- 1Survey of Society of Breast Imaging members evaluated FDA-cleared breast cancer AI detection tool adoption and impact.
- 2Few radiologists believe current AI contributes significant clinical benefits or decisively improves outcomes.
- 3Although daily use is rising, most users report only minor improvements and little to no financial gain.
- 4A related EuroAIM/EuSoMII 2024 survey found nearly half of respondents use AI, but most saw minimal workload reduction.
- 5Anticipated benefits, like improved outcomes or efficiency, are not widely realized so far in clinical practice.
Why It Matters
This suggests a gap between the promise of AI in breast imaging and its real-world impact, informing future research, tool development, and adoption strategies. Understanding these limitations can guide expectations and investment in imaging AI.
Source
Radiology Business
Related News
•Radiology Business
AI Model Surpasses Radiologists in Detecting Subtle Hip Fractures
A new AI model outperformed radiologists in identifying difficult-to-detect femoral neck fractures on radiographs.
•Radiology Business
UCLA Review Evaluates Breast AI for Early Cancer Detection
A UCLA-led review analyzes current evidence for AI tools in screening mammography, focusing on their capability to detect interval cancers.
•AuntMinnie
AI-Driven Whole-Body MRI Biomarkers Aid Myeloma Risk Stratification
AI-powered MRI analysis offers automated risk stratification via body composition in multiple myeloma patients.